As Lundbeck and Otsuka count on prescriptions in agitation associated with dementia due to Alzheimer’s disease (AADAD) to continue driving growth for Rexulti, the duo is supporting new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results